All News #Library
Others
Ferrer offers $122M biobucks for ex-US license to Verge ALS drug
25 Mar 2024 //
PRESS RELEASE
Verge Genomics Appoints Diego Cadavid, M.D., as Chief Medical Officer
06 Dec 2022 //
BUSINESSWIRE
Verge Genomics to Present at Upcoming Investor Conferences in November
21 Nov 2022 //
BUSINESSWIRE
Alice Zhang Recognized as a Pioneer in AI-Driven Drug Discovery
14 Nov 2022 //
BUSINESSWIRE
Verge Genomics Initiates First-In-Human Dosing in Phase 1 Trial of VRG50635
31 Oct 2022 //
BUSINESSWIRE
Verge Genomics takes AI-sourced drug for ALS into clinic
31 Oct 2022 //
PHARMAPHORUM
Verge Genomics Appoints John Applegate as Chief Financial Officer
17 Oct 2022 //
BUSINESSWIRE
Verge Genomics Secures $98 Million in New Financing
16 Dec 2021 //
BUSINESSWIRE

Market Place
Sourcing Support